Kishan Mehta

CIK 1850520 · last filed 2026-03-19

Kishan Mehta is a corporate insider who has filed 11 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for BHVN, was dated Mar 19, 2026. Current disclosed insider exposure totals $255.6K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$255.6K

Companies

3

Total Filings

11

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BHVN Director 22,662 $11.28 $255.6K $0 7 2026-03-19
BNTC Director $11.18 $0 2 2025-12-03
Biohaven Pharmaceutical Holding Co Ltd. (BHVNw) Delisted Director 0 $0 1 2022-10-03

Recent Filings

11 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-03-19 BHVN Gift (G) $0 EDGAR
2025-12-03 BNTC Grant (A) $0 EDGAR
2025-05-07 BHVN Grant (A) $0 EDGAR
2024-12-11 BNTC Grant (A) $0 EDGAR
2024-05-02 BHVN Grant (A) $0 EDGAR
2023-05-04 BHVN Grant (A) $0 EDGAR
2022-10-05 Mixed +22,662 $5.8K
2022-10-03 Biohaven Pharmaceutical Holding Co Ltd. (BHVNw) Delisted Disp (D) −10,640 -$1.58M EDGAR
2022-04-29 BHVN Grant (A) $0 EDGAR
2022-01-12 BHVN Exer (M) +1,875 $0 EDGAR
Showing 110 of 11
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.